César Alejandro
Soutullo Esperón
Chercheur jusqu' 2019
![Foto de César Alejandro](/img/nophoto.png)
![Foto de Summit Health Institute for Research and Education](/img/noimage_org.png)
Summit Health Institute for Research and Education
Washington, Estados UnidosPublications en collaboration avec des chercheurs de Summit Health Institute for Research and Education (4)
2018
-
Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
CNS Drugs, Vol. 32, Núm. 5, pp. 455-467
-
Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: A descriptive analysis
BMC Psychiatry, Vol. 18, Núm. 1
2017
-
Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
CNS Drugs, Vol. 31, Núm. 7, pp. 625-638
2014
-
Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/ hyperactivity disorder in a randomized, Controlled trial
Neuropsychiatric Disease and Treatment, Vol. 10, pp. 2039-2047